Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 4, Issue 8, Page 7 (August 2008)


View previous. 9 of 30 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (78 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

Partial Dopamine Agonist Provides Benefits in Early PD

PATRICE WENDLING (Chicago Bureau)

CHICAGO — Monotherapy with the investigational agent pardoprunox significantly improved symptoms in patients with early-stage Parkinson's disease in a multicenter phase II clinical trial.

PII: S1553-3212(08)70254-1

doi:10.1016/S1553-3212(08)70254-1


View previous. 9 of 30 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.